Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: Austria Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20141
20152
20172
20181
20191
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arbeitsgemeinschaft medikamentoese Tumortherapie2
Celgene2
Novartis Pharmaceuticals2
Genmab1
Insel Gruppe AG, University Hospital Bern1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Karyopharm Therapeutics Inc1
Miltenyi Biomedicine GmbH1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse12
Lymphoma, Non-Hodgkin3
Dendritic Cell Sarcoma, Interdigitating2
Lymphoma2
Lymphoma, Follicular2
Recurrence2
Burkitt Lymphoma1
Hematologic Neoplasms1
Lymphoma, B-Cell1
Lymphoma, Mantle-Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.